anidulafungin has been researched along with Fungemia in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (62.96) | 29.6817 |
| 2010's | 10 (37.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, N; Chamilos, G; Kontoyiannis, DP; Lewis, RE | 1 |
| Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL | 1 |
| Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS | 1 |
| Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS | 1 |
| Bellanger, AP; Cervoni, JP; Deconinck, E; Faucher, JF; Ginet, M; Grenouillet, F; Weil-Verhoeven, D | 1 |
| Aksu, N; Aypak, A; Hazirolan, G | 1 |
| Chen, FL; Hsueh, PR; Lee, WS; Wang, CH | 1 |
| Capilla, J; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, NP | 1 |
| Joseph, JM; Kim, R; Reboli, AC | 1 |
| Cuenca-Estrella, M; Gurguí, M | 1 |
| Almirante, B; Pemán, J | 1 |
| Aguado, JM; Ayats, J | 1 |
| Borges Sá, M; Garnacho Montero, J | 1 |
| Ruiz Camps, I; Vázquez López, L | 1 |
| Gadea, I; Mensa, J | 1 |
| Dybas, L; El-Mortada, M; Havlichek, D; Prince, R; Smith, C; Stein, GE | 1 |
| Sganga, G | 1 |
| Cervera, C; Escorsell, A; Linares, L; Moreno, A; Reverté, E | 1 |
| Aigner, M; Lass-Flörl, C; Mayr, A | 1 |
| Arendrup, MC; Axner-Elings, M; Botero-Kleiven, S; Jensen, RH | 1 |
| Demitrovicova, A; Kisac, P; Krcmery, V | 1 |
| Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J | 1 |
| Goldstein, BP; Henkel, T; Krause, DS; Reboli, A; Reinhardt, J; Vazquez, JA; Wible, M | 1 |
| Bennett, JE | 1 |
| Betts, R; Chapman, SW; Goldstein, BP; Kett, DH; Krause, DS; Kumar, D; Pappas, PG; Reboli, AC; Rotstein, C; Schranz, J; Walsh, TJ; Wible, M | 1 |
| Revankar, SG; Sobel, JD | 1 |
| Catalán González, M; León Gil, C; Montejo González, JC | 1 |
10 review(s) available for anidulafungin and Fungemia
| Article | Year |
|---|---|
Anidulafungin: a drug evaluation of a new echinocandin.
Topics: Anidulafungin; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Esophagus; Fungemia; Humans; Mycoses; Oropharynx | 2008 |
[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; beta-Glucans; Candidiasis; Clinical Trials as Topic; Critical Care; Diabetes Complications; Disease Susceptibility; Echinocandins; Fungemia; Galactose; Hematologic Diseases; Humans; Immunocompromised Host; Mannans; Meta-Analysis as Topic; Mycoses; Neoplasms; Opportunistic Infections | 2008 |
[Current treatment of candidemia. Role of anidulafungin].
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Double-Blind Method; Drug Resistance, Fungal; Echinocandins; Fluconazole; Fungemia; Gastrointestinal Diseases; Global Health; Humans; Middle Aged; Multicenter Studies as Topic; Neutropenia; Risk Factors; Species Specificity | 2008 |
[Role of anidulafungin in solid organ transplant recipients].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Interactions; Echinocandins; Fungemia; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Organ Transplantation; Postoperative Complications; Premedication; Risk Factors | 2008 |
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic | 2008 |
[Potential of anidulafungin in hematological patients].
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Azoles; Candidiasis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echinocandins; Fungemia; Hematologic Diseases; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Kidney Diseases; Liver Diseases; Mice; Neutropenia; Risk Factors | 2008 |
[Potential of anidulafungin in combined therapy].
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Encephalomyelitis; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Mice; Mycoses | 2008 |
Anidulafungin for the treatment of invasive candidiasis.
Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Cost-Benefit Analysis; Echinocandins; Fungemia; Humans; Incidence; Intensive Care Units; Randomized Controlled Trials as Topic | 2011 |
Echinocandins for candidemia in adults without neutropenia.
Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fungemia; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic | 2006 |
[Therapeutic efficacy of anidulafungin for the treatment of oesophageal candidiasis, candidemia and invasive candidiasis].
Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Esophagitis; Fungemia; Humans | 2008 |
2 trial(s) available for anidulafungin and Fungemia
| Article | Year |
|---|---|
Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; APACHE; Candidiasis; Dose-Response Relationship, Drug; Echinocandins; Female; Fungemia; Humans; Male; Middle Aged; Peptides, Cyclic; Prospective Studies | 2004 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Double-Blind Method; Echinocandins; Female; Fluconazole; Fungemia; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Peptides, Cyclic; Treatment Outcome | 2007 |
15 other study(ies) available for anidulafungin and Fungemia
| Article | Year |
|---|---|
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.
Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fungemia; Humans; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Species Specificity | 2007 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity | 2008 |
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged | 2008 |
Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungemia; Hepatic Insufficiency; Humans; Liver Transplantation; Lymphoma; Male; Middle Aged; Paecilomyces | 2017 |
An unusual case of urinary tract infection caused by Saprochaete capitata under anidulafungin treatment.
Topics: Aged; Anidulafungin; Antifungal Agents; Diabetes Complications; Echinocandins; Female; Fungemia; Humans; Saccharomycetales; Turkey; Urinary Tract Infections | 2017 |
Breakthrough fungemia caused by Rhodotorula mucilaginosa during anidulafungin therapy.
Topics: Aged, 80 and over; Anidulafungin; Antifungal Agents; Drug Resistance, Fungal; Fatal Outcome; Fungemia; Humans; Male; Rhodotorula | 2019 |
Efficacy of echinocandins against murine infections by Diutina (Candida) rugosa.
Topics: Anidulafungin; Animal Structures; Animals; Antifungal Agents; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fungemia; Lipopeptides; Male; Mice; Saccharomycetales; Survival Analysis; Treatment Outcome | 2016 |
Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Echinocandins; Female; Fungemia; Humans; Male; Microbial Viability; Middle Aged; Serum; Young Adult | 2010 |
Case report 4: Elderly patient with concomitant conditions.
Topics: Aged; Anidulafungin; Antifungal Agents; Bacteremia; Candida; Candidiasis; Echinocandins; Enterococcus faecalis; Female; Fungemia; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Peritonitis; Radiography, Abdominal; Tomography, X-Ray Computed | 2010 |
Case report 6: Candidaemia in a high risk liver transplant recipient.
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Bronchitis; Candida albicans; Candidiasis; Echinocandins; Female; Fluconazole; Fungemia; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Liver Failure; Liver Transplantation; Postoperative Complications; Stenotrophomonas maltophilia; Transplantation; Treatment Outcome; Young Adult | 2010 |
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation, Missense; Sweden | 2011 |
Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.
Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Slovakia; Treatment Outcome; Triazoles | 2011 |
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole | 2003 |
Echinocandins--first-choice or first-line therapy for invasive candidiasis?
Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Peptides, Cyclic | 2007 |